SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-20-000005
Filing Date
2020-01-28
Accepted
2020-01-28 16:46:14
Documents
6
Period of Report
2020-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kpressrelease.htm 8-K 40188
2 EXHIBIT 1.1 a11-underwritingagreement.htm EX-1.1 274372
3 EXHIBIT 4.1 a41-prexfundedwarrant.htm EX-4.1 98179
4 EXHIBIT 5.1 a51-goodwinopinion.htm EX-5.1 8111
5 EXHIBIT 99.1 a991-pressrelease.htm EX-99.1 10107
6 concertimage8ka09.jpg GRAPHIC 15744
  Complete submission text file 0001367920-20-000005.txt   454019
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 20554990
SIC: 2834 Pharmaceutical Preparations